| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension
|
Shafran, Inbal
|
|
|
12 |
6 |
p. 1089-1097
|
article
|
| 2 |
Asymmetric Dimethylarginine in Pulmonary Arterial Hypertension
|
Thenappan, Thenappan
|
|
|
12 |
6 |
p. 1098-1100
|
article
|
| 3 |
Correction
|
|
|
|
12 |
6 |
p. 1136-1140
|
article
|
| 4 |
From Mechanisms to Phenotypes
|
Vest, Amanda R.
|
|
|
12 |
6 |
p. 1012-1014
|
article
|
| 5 |
Full issue PDF
|
|
|
|
12 |
6 |
p. e1-e168
|
article
|
| 6 |
Hard Work and Talent in the Battle Against Heart Failure ∗
|
Baran, David A.
|
|
|
12 |
6 |
p. 1071-1072
|
article
|
| 7 |
Heart Failure With Preserved Ejection Fraction in Patients With Atrial Fibrillation
|
Zakeri, Rosita
|
|
|
12 |
6 |
p. 1026-1029
|
article
|
| 8 |
Illuminating a Hidden Risk
|
Ammirati, Enrico
|
|
|
12 |
6 |
p. 1112-1114
|
article
|
| 9 |
Medicare’s Canopy to the Roots of Heart Failure Management
|
Echols, Melvin R.
|
|
|
12 |
6 |
p. 1056-1058
|
article
|
| 10 |
Middle-Aged Children With Heart Failure
|
Guglin, Maya
|
|
|
12 |
6 |
p. 1134
|
article
|
| 11 |
National Trends in Hospital Performance in Guideline-Recommended Pharmacologic Treatment for Heart Failure at Discharge
|
Hess, Paul L.
|
|
|
12 |
6 |
p. 1059-1070
|
article
|
| 12 |
Palliative Care Across the Spectrum of Heart Failure
|
Gelfman, Laura P.
|
|
|
12 |
6 |
p. 973-989
|
article
|
| 13 |
Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries
|
Mentias, Amgad
|
|
|
12 |
6 |
p. 1044-1055
|
article
|
| 14 |
Pre-Heart Failure, Heart Stress, and Subclinical Heart Failure
|
Bayes-Genis, Antoni
|
|
|
12 |
6 |
p. 1115-1118
|
article
|
| 15 |
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis
|
Monda, Emanuele
|
|
|
12 |
6 |
p. 1101-1111
|
article
|
| 16 |
Pulse Pressure Response to Inotrope Therapy in Cardiogenic Shock
|
Han, Jiho
|
|
|
12 |
6 |
p. 1126-1127
|
article
|
| 17 |
Real-World Experience and 36-Week Outcomes of Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten
|
Reza, Nosheen
|
|
|
12 |
6 |
p. 1123-1125
|
article
|
| 18 |
Reply
|
Yang, Fen
|
|
|
12 |
6 |
p. 1135
|
article
|
| 19 |
Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF
|
Reddy, Yogesh N.V.
|
|
|
12 |
6 |
p. 990-998
|
article
|
| 20 |
Serum Markers of Neurodegeneration Are Strongly Linked to Heart Failure Severity and Outcome
|
Wurm, Raphael
|
|
|
12 |
6 |
p. 1073-1085
|
article
|
| 21 |
Sex Differences in Heart Failure With Improved Ejection Fraction
|
Pabón, Maria A.
|
|
|
12 |
6 |
p. 1119-1122
|
article
|
| 22 |
Smartphone-Based Recognition of Heart Failure by Means of Microelectromechanical Sensors
|
Haddad, Francois
|
|
|
12 |
6 |
p. 1030-1040
|
article
|
| 23 |
Targeted Metabolomic Profiling of Dapagliflozin in Heart Failure With Preserved Ejection Fraction
|
Selvaraj, Senthil
|
|
|
12 |
6 |
p. 999-1011
|
article
|
| 24 |
The Link Between Heart Failure and Neurodegeneration
|
Traub, Jan
|
|
|
12 |
6 |
p. 1086-1088
|
article
|
| 25 |
The Year in Review in Heart Failure
|
Bozkurt, Biykem
|
|
|
12 |
6 |
p. 1128-1133
|
article
|
| 26 |
Use of Digital Devices in Patients With Heart Failure ∗
|
Kose, Orhun
|
|
|
12 |
6 |
p. 1041-1043
|
article
|
| 27 |
Utility and Validity of the HFA-PEFF and H2FPEF Scores in Patients With Symptomatic Atrial Fibrillation
|
Ariyaratnam, Jonathan P.
|
|
|
12 |
6 |
p. 1015-1025
|
article
|
Journal description